# Exposure of intestinal explants to NX, but not to DON, enriches the secretome in mitochondrial proteins

Laura Soler-Vasco, Ingrid Miller, Chloé Terciolo, Karin Hummel, Katharina

Nöbauer, Manon Neves, Isabelle Oswald

► To cite this version:

Laura Soler-Vasco, Ingrid Miller, Chloé Terciolo, Karin Hummel, Katharina Nöbauer, et al.. Exposure of intestinal explants to NX, but not to DON, enriches the secretome in mitochondrial proteins. Archives of Toxicology, 2022, 10.1007/s00204-022-03318-x. http://hal-03702831

HAL Id: hal-03702831

https://hal.inrae.fr/hal-03702831

Submitted on 23 Jun 2022

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Exposure of intestinal explants to NX, but not to DON, enriches the secretome in mitochondrial proteins

Laura Soler<fnref n="1" /> ID • Ingrid Miller<fnref n="2" /> ID • Chloé Terciolo<fnref n="1" /> ID • Karin Hummel<fnref n="3" /> ID • Katharina Nöbauer<fnref n="3" /> ID • Manon Neves<fnref n="1" /> ID • Isabelle P. Oswald<fnref n="1" /> ID

Received: 17 February 2022 / Accepted: 12 May 2022

© The Author(s) 2022

## Abstract

NX is a type A trichothecene produced by *Fusarium graminearum* with limited information on its toxicity. NX is structurally similar to deoxynivalenol (DON), only differing by the lacking keto group at C8. Because of the structural similarity of the two toxins as well as their potential co-occurrence in food and feed, it is of interest to determine the toxicity of this new compound. In this study, we compared the protein composition of the extracellular media of pig intestinal explants (secretome) exposed to 10 µM of DON or NX for 4 h compared with controls. The combination of two complementary quantitative proteomic approaches (a gel-based and a gel-free approach) identified 18 and 23 differentially abundant proteins (DAPs) for DON and NX, respectively, compared to controls. Functional analysis suggested that, whereas DON toxicity was associated with decreased cell viability and cell destruction, NX toxicity was associated with an enrichment of mitochondrial proteins in the secretome. The presence of these proteins may be associated with the already known ability of NX to induce an intestinal inflammation. Overall, our results indicated that DON- and NX-induced changes in the extracellular proteome of intestinal explants are different. The increased leakage/secretion of mitochondrial proteins by NX may be a feature of NX toxicity.

**Keywords** Deoxynivalenol • NX • Gut • *Fusarium graminearum* • Explant • Proteome

## Introduction

Various filamentous fungi, mainly from the genera *Aspergillus*, *Penicillium*, and *Fusarium* produce secondary metabolites in food and feed known as mycotoxins that are toxic to both humans and animals (Payros et al. 2021a).

In temperate climates, infections of wheat and corn by the pathogen *F. graminearum* and related species are a chronic

problem. The resulting food and feed is contaminated with the mycotoxin deoxynivalenol (DON; Miller 2016). In Europe and Asia, exposure to DON can approach or exceed the tolerable daily intake, especially in children (JEFCA 2011; Knutsen et al. 2017; Vin et al. 2020).

A decade ago, a genetic population of *F. graminearum* was discovered that produced the novel trichothecene NX, an analogue of DON lacking the carbonyl moiety at the C8-position (Fig. 1) (Varga et al. 2015; Aitken et al. 2019; Chen et al. 2022). NX is biosynthesized by new chemotypes of *F. graminearum* populations first identified in the Midwest United States (Gale et al. 2010; Crippin et al. 2019). DON and NX have been demonstrated to co-occur. Analyses of corn samples that contained high amounts of DON have found NX at 1–7% of the DON concentration (Crippin et al. 2020).

Because it is a high human exposure toxin, much effort has been spent to understand the mechanisms of toxicity of DON. At a cellular level, DON interacts with the peptidyl transferase region of the 60S ribosomal subunit (Garreau de Loubresse et al. 2014). It induces ribotoxic stress, triggering an inflammatory cascade mediated by the activation

Laura Soler and Ingrid Miller shared first authorship.

<figure><img src="image_2.png" /></figure>

Laura Soler
laura.soler@inrae.fr

<figure><img src="image_3.png" /></figure>

Ingrid Miller
Ingrid.miller@vetmeduni.ac.at

<footnote n="1">¹ Toxalim (Research Centre in Food Toxicology), INRAE, ENVT, INP-Purpan, UPS, Université de Toulouse, Toulouse, France</footnote>

<footnote n="2">² Institute of Medical Biochemistry, University of Veterinary Medicine Vienna, Veterinaerplatz 1, 1210 Vienna, Austria</footnote>

<footnote n="3">³ VetCore Proteomics, University of Veterinary Medicine Vienna, Veterinaerplatz 1, 1210 Vienna, Austria</footnote>
<figure><img src="image_4.png" /><figcaption>**Fig. 1** Structural formulas of the two mycotoxins in this study, DON (deoxynivalenol) and NX</figcaption></figure>

of mitogen-activated protein kinases (MAPKs) and oxidative stress that leads to apoptosis (Pestka 2010; Lucioli et al. 2013; Payros et al. 2016). The toxic effects associated with DON exposure include alterations on protein synthesis, immune system function, and intestinal functions (Pestka 2010; Pinton and Oswald 2014). DON also interacts with several appetite suppression systems (Terciolo et al. 2018).

The toxicological characterization of NX, however, is far from complete. The few available data show that NX and DON share similar mechanisms of toxicity, including a similar inhibition of protein biosynthesis, as well as cytotoxicity, oxidative stress-related, and pro-inflammatory effects (Varga et al. 2015, 2018; Woelflingseder et al. 2018, 2020).

Recently, the comparative intestinal toxicity of DON and NX was assessed with human intestinal epithelial cells and porcine jejunal explants (Pierron et al. 2022). Both toxins had a similar impact on the viability of human intestinal epithelial cells in vitro. However, NX displayed a greater toxicity to pig intestinal explants as evidenced by the observed histopathological lesions and the results of genome-wide analysis. Gene expression data suggested that the two toxins targeted the same molecular processes namely inflammation, immune response, cell proliferation, differentiation, apoptosis, and growth. Differences between the two toxins were limited to a higher number of genes regulated per pathway as well as a higher magnitude of the gene expression changes in tissues exposed to NX (Pierron et al. 2022).

Both to assess structure-activity relationships in this class of trichothecene and the potential for DON and NX to co-occur, it is important to understand the risk associated with these toxins. Indeed, the investigation of the interaction between these molecules requires a clear understanding of the toxic impacts of each. One of the preferred approaches in clinical systems biology used to identify relevant mechanistic differences and their associated potential biomarkers is the study of tissue-specific leakage and secreted proteins (commonly referred to as the secretome) using proteomics (Hathout 2007). These are proteins that normally function inside cells, but can be released into plasma due to specific trafficking, signaling, or cell damage. The secretome includes many of the most important diagnostic markers in

clinical investigations. This would include for example cardiac troponins for myocardial infarction, and liver enzymes for hepatocellular damage (Lai et al. 2010).

The objective of this study was to combine two complementary quantitative proteomic approaches (a gel-based and a gel-free method) to characterize and compare the secretomes of pig intestinal explants exposed to DON and NX with the aim of identifying specific toxic effects of each mycotoxin.

## Materials and methods

### Experimental design and statistical rationale

An ex vivo model based on pig jejunal explants was used in the present study. This model is convenient to study the molecular events that depend on interaction between the different intestinal cellular types as well as signaling gradients present along the crypt-villus axis. The model also allows for the analysis of control-treated paired explants, thus accounting individual variability. Pig intestinal explants were used as surrogates of human tissues. Pig is a good model for extrapolation to humans, as their digestive physiology is very similar to that of humans (Swindle 2012). Moreover, the intestinal explant model using post-weaning animals as tissue donors is suitable for analysis of the intestinal toxicity of trichothecenes (Kolf-Clauw et al. 2013; Alassane-Kpembi et al. 2017a, b; Graziani et al. 2019). Because the exposure time is limited to 4 h when intestinal explants are used due to the greater possibility of tissue degradation with longer incubation times, the concentrations of both toxins were set at 10 µM. This strategy is recommended in proteomic studies in toxicology (Rabilloud and Lescuyer 2015), because this concentration is high enough to give useful insights into the specific molecular mechanisms involved in toxic injury. Moreover, examination at an early time point ensures that cell mortality is low enough to avoid pollution of proteomic analysis by events that are strictly related to cell death.

Two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) confirmed by immunoblotting was

<figure><img src="image_5.png" /></figure>
performed in six-paired control and treated samples. Paired t tests (GraphPad Software, San Diego, CA, USA) and paired ratios were used to analyze differences in protein abundance in all cases. Selection criteria for spots defined as differentially regulated between control and DON- or NX-treated samples from the same animal were a fold-change of ≥ 1.5 or ≤ 0.67, presence in at least eight out of 12 gel images per group and appropriate spot quality. Differentially abundant proteins (DAPs) detected in at least one animal were listed and used for functional analysis. Label-free liquid chromatography-mass spectrometry (LC-MS/MS) was performed with three biological replicates in each group (control, NX, and DON). T tests in a nested design were performed in Proteome Discoverer 2.4 with a pairwise comparison. The significance level was set to an adjusted *p* value ≤ 0.05 and fold-change ratios of ≥ 2 or ≤ 0.5. Because fewer animals were included using this approach, only DAPs detected in all animals were listed and used for functional analysis.

## Sample preparation

DON was purchased from Sigma-Aldrich (St. Quentin Fal-lavier, France). NX (deacetylated product 7a-hydroxy, 3, 15-dideacetylcalonectrin), a kind gift from Dr JD Miller, was obtained as described elsewhere (Aitken et al. 2019). Toxins were dissolved in purified water and were stored aliquoted at a stock concentration of 5 mM at -20 °C. A total of six 4-week-old crossbred female piglets were used. The experiment was conducted following the guidelines of the French ministry of agriculture for animal research. All animal experimentation procedures were approved by the Ethics Committee of pharmacology-toxicology of Toulouse-Midi-Pyrénées in animal experimentation (Tox-cométhique) (No. TOXCOM/0163/PP) in accordance with the European Directive on the protection of animals used for scientific purposes (Directive, 2010/63/EU). Jejunal explants were obtained as previously described (Lahjouji et al. 2020) and rinsed for 30 min in complete cell con-trol medium. Medium free of bovine fetal serum was used to avoid polluting secretomes with foreign proteins, and included William's Medium E (Sigma-Aldrich), glucose 4.5 g/L (Sigma-Aldrich), ITS (insulin transferrin sodium selenite) 1× (Sigma-Aldrich), alanyl-glutamine 30 mM (Sigma-Aldrich), 1% penicillin-streptomycin, and 0.5% gentamycin (Eurobio). Explants were exposed to 10 µM of DON, NX or vehicle (water) at 39 °C for 4 h under conditions described elsewhere (Alassane-Kpembi et al. 2017b; García et al. 2018). After incubation, the medium was recovered (3 mL), and debris was discarded by cen-trifugation at 5000g for 15 min. Concentrated secretomes were obtained using ultrafiltration centrifugal filter units until volumes were reduced approximately tenfold (Amicon Ultra-2 mL Centrifugal Filters 3 kDa MWCO,

Merck-Millipore, Darmstadt, Germany). Total protein concentration was determined using the Bradford method (Bradford 1976) and samples were kept at -80 °C until analysis.

## 2D-DIGE analysis (gel-based approach)

Two-dimensional electrophoresis with CyDye-labeled samples (2D-DIGE) was performed as previously described (Miller 2012; Gebhard et al. 2018). Appropriate amounts of concentrated secretomes (25 µg protein per 2D gel and sample) were freeze-dried, re-dissolved in DIGE labelling buffer, and minimally labelled with CyDyes (Cytiva, Vienna, Austria). A Cy2-labelled pool of all samples was used as internal standard, Cy3 and Cy5 were used for single samples in a reverse labelling setup. The whole set contained six biological replicates per group. Per gel, a pool of two labelled samples (Cy3, Cy5) and the internal standard (Cy2) underwent isoelectric focusing in 10 cm IPG pH 4–10 NL homemade strips prior to SDS-PAGE in 140×140×1.5 mm gradient gels (T= 10–15%, C=2.7%). Images were captured on a Typhoon RGB and evaluated with DeCyder V5.02 software (both Cytiva).

For protein identification, 2D-DIGE gels were silver stained under MS-compatible conditions (Miller 2012). Selected spots of sufficient intensity and quality (for regulation criteria see above) were excised manually. Samples were prepared and mass spectrometric analysis was performed according to Gutiérrez et al. (2019). Briefly, silver stained spots were de-stained using potassium hexacyanoferrate (III) and sodium thiosulfate. After several washing steps with ammonium bicarbonate supported by ultrasonication, proteins were reduced with dithiothreitol and alkylated with iodoacetamide. Digestion was performed with trypsin overnight. Extracted and dried peptides were dissolved in 0.1% TFA (trifluoroacetic acid) for LC-MS/MS analysis applying a 390 min LC gradient. Detailed parameters for the nano-LC Orbitrap MS/MS are provided in Gutiérrez et al. (2019).

A database search was performed using the Proteome Discoverer software 2.4.0.305 (Thermo Fisher Scientific, USA) in the UniProt database of Sus Scrofa (TX: 9823) as well as the cRAP database (https://www.thegpm.org/crap/). Full tryptic cleavage was allowed with a maximum of two missed cleavage sites, a precursor mass tolerance of 10 ppm and a fragment mass tolerance of 0.02 Da. For the search, carbamidomethylation (+57.021 Da) of cysteine as a static modification was used, whereas oxidation of methionine (+15.995 Da) and N-terminal acetylation (+42.011 Da) were set as variable modifications.
## Label-free LC-MS/MS (gel-free analysis)

For the label-free LC-MS/MS, 30 µg of each sample were digested using the FASP protocol on 10 kDa filters (Pall, New York, NY, USA) with slight modifications. The filter units were washed twice with 500 µL 8 M urea in 50 mM tris (pH 8.0) and centrifuged for 20 min at 10,000g, and once with 300 µL and centrifuged for 15 min at 10,000g. The proteins in the samples were reduced (200 mM dithiothreitol, 37 °C, 30 min) and alkylated (500 mM iodoacetamide, 37 °C, 30 min) on the filter on a thermomixer (Eppendorf, Germany). Next, the samples were centrifuged for 15 min at 10,000g and washed twice with 100 µL 50 mM tris (pH 8.0), and then centrifuged for 15 min at 10,000g. Digestion was carried out using Trypsin/LysC Mix (Thermo Fisher Scientific, Waltham, MA, USA) in a ratio of 1:25 (Protease: protein) overnight at 37 °C. Digested peptides were recovered by centrifugation for 15 min (10,000g) and with three times 50 µL of 50 mM tris and 15 min centrifugation each time. The resulting peptide solution was acidified with 1 µL concentrated TFA for subsequent desalting and clean-up using C18 spin columns (Pierce, Thermo Fisher Scientific) according to the manufacturer's protocol. The dried peptides were re-dissolved in 300 µL 0.1% TFA of which 3 µL were injected to the nano-LC-MS system (Ultimate 3000 RSLC, QExactive HF, Thermo, Waltham, MA, USA).

The LC-MS/MS analysis was done as described above with just a longer gradient used. The step from 4 to 31% B was prolonged to 60 min. The MS database search was also performed as given in "2D-DIGE analysis (gel-based approach).

## Functional analysis

To assess which cell compartments/functions/pathways were mainly represented by the peptides/proteins analyzed, a system biology analysis was performed using combined lists of DAPs from the two proteomic approaches. In brief, the UniProtKB accession numbers from all DAPs were recovered and listed. From these numbers, the official human gene symbols (HuGO Gene Nomenclature Committee) were retrieved from Sus scrofa annotated proteins, whereas uncharacterized proteins were mapped to the corresponding *Homo sapiens* orthologs by identifying the reciprocal best BLAST hits. The list of proteins showing differential abundance was uploaded in DAVID Bioinformatic database v6.8 software (Huang et al. 2009) to obtain an overview of Gene Ontology (GO) terms for the cellular compartment, molecular function, and biological processes in which DAPs are involved. The list of proteins showing differential abundance was also uploaded onto Ingenuity Pathway Analysis (IPA) (Qiagen Bioinformatics, Hilden, Germany) and mapped to the respective databases of each tool. IPA uses

networks, diseases, and molecular and cellular functions generated from previous publications and public protein interaction databases using the Ingenuity Knowledge Base as a reference.

## Immunoblotting analysis

Proteomic results were checked by immunoblotting using a cross-reacting antibody for the human protein ATP synthase F1 subunit beta (ATP5F1B; ABclonal, Woburn, MA, USA), a protein that shows differential abundance according to both 2D-DIGE and label-free LC-MS/MS analysis.

The procedure was performed as previously described (Miller et al. 2006), with modifications. Appropriate amounts of (unlabeled) samples were separated on SDS-PAGE on 10–15% T gradient gels over a separation distance of 8 cm and semi-dry blotted onto nitrocellulose (Cytiva). After fluorescence staining of the protein patterns with RuBPS (ruthenium (II) tris bathophenanthroline disufonate) and scanning on the Typhoon RGB, membranes were incubated in primary and secondary antibodies (cross-absorbed anti-rabbit IgG-HRPO, Novex, Life Technologies, Grand Island, NY, USA). Immunoreactive bands were detected by ECL (Clarity Western ECL substrate, Bio-Rad, Hercules, CA, USA) on a Vilber Lourmat FX system (Vilber-Lourmat, Eberhardzell, Germany). The overall protein staining pattern was used as a loading control and for normalization during band intensity quantification using Fiji software (ImageJ).

## Results and discussion

2D-DIGE analyses revealed differences in spot intensity between controls and DON samples in 27 matched spots, whereas 56 matched spots in NX samples differed significantly (a change of at least 50%) from controls. Of these, respectively, 15 and eight spots were positively identified by MS (Fig. 2; Supplementary Tables S1, S2). One animal was excluded from the analysis, because it showed an abnormal pattern of NX-treated samples, suggesting a technical problem. The list of differentially abundant proteins was completed with those detected by label-free LC-MS analysis, namely three proteins in DON samples and 16 in NX samples ($P \le 0.05$; fold-change $\ge 2$ or $\le 0.5$) (Supplementary Table S3). Five proteins (APOA4, ATP5F1B, CCT8, HSPA5, and MMP1) were differentially accumulated in response to both toxins, and one of them, ATP5F1B, was found to be a DAP in both proteomic analyses (2D-DIGE and LC-MS/MS). This last protein was used to check proteomics data, and immunoblotting analysis confirmed the results (Fig. 3).

The secretomes of intestinal explants exposed to DON showed a majority of DAPs involved in structural functions
<figure><img src="image_6.png" /><figcaption>**Fig. 2** 2D separation of secretome, DIGE-gel after silver staining. Shown sample: mix of secretomes (equal amounts of CyDye-labeled control, NX-treated secretome and internal standard). Red circles indicate spots found differentially abundant in comparison to control sample and were subjected to LC-MS/MS analysis for protein identification. Labels according to gene names of the respective proteins (UniProt database); for full names, see Tables 1 and 5; for regulation and identification data, see supplemental tables S1 and S2 (color figure online)</figcaption></figure>

(8 DAPs), together with proteins with roles in metabolism
(5 DAPs) and other functions (5 DAPs, Table 1).

Functional analysis indicated that these proteins were
either located in extracellular vesicles or were cytosolic or
cytoskeletal/junctional proteins (Table 2).

The most affected molecular and biological processes were linked with cell adhesion as well as cell trafficking and shape (Tables 2 and 3). These results show that the secretomes of jejunal explants exposed to DON are markers of cell damage, loss of cell adhesion, and altered metabolism. Likewise, the top canonical pathways regulated by DON evidenced changes in glucose metabolism and enhanced detoxification (Table 4).

Our results are in agreement with the known toxicity
of DON that causes lesions in the intestine and the loss of
the intestinal barrier (Pinton et al. 2009, 2012; Payros et al.
2021b). Indeed, the enrichment of structural proteins as well
as of proteins involved in metabolism known to be present in
mature enterocytes in the DON intestinal secretomes reflects
increased destruction of the intestinal epithelium, and the
release of cytosolic proteins into the medium. Although the
pro-inflammatory role of DON is well known (Pestka 2010;
Alassane-Kpembi et al. 2018; Payros et al. 2020), the intes-
tinal secretomes contained no inflammatory proteins, prob-
ably due to the short exposure time to the toxin. Indeed, the
production and release of inflammatory proteins may take
more than 4 h. However, the changes observed in glucose
metabolism and detoxification processes as well as changes
in cellular chaperones such as HSPA5 reflect a high cellular
stress, which may indeed be linked with the development of
an inflammation.

<figure><img src="image_7.png" /><figcaption>**Fig. 3** SDS-PAGE of secretomes (from tissue with/without exposure to the respective mycotoxins) and with immunoblot against anti-ATP5F1B (ATP synthase F1 subunit beta). A ATP5F1B band intensities in controls, NX and DON-treated supernatants (n=5 per group), all normalized onto the overall protein stain of the respective lane (in AU arbitrary units); significant differences were calculated relative to untreated control (Student's t test, paired, two sided; *, p<0.05). B Blot example of one animal in immunostaining (top) and overall protein stain which was used for normalization (bottom; same lanes as shown for specific stain). C is for control, DON for deoxynivalenol</figcaption></figure>
<table><caption>**Table 1** Proteins in the secretomes of intestinal explants (n = 5 for 2D-DIGE; n = 3 for label-free LC-MS/MS analysis) which were differentially regulated due to exposure to DON (deoxynivalenol)</caption><thead><tr><th>Technique</th><th>Official gene symbol</th><th>Name</th><th>Subcellular location</th><th>Function</th></tr></thead><tbody><tr><td colspan="5"><strong>Structural proteins</strong></td></tr><tr><td>2D-DIGE</td><td>CCT8</td><td>Chaperonin containing TCP1 Subunit 8</td><td>Nucleoplasm, intermediate filaments, cytosol</td><td>Involved in the transport and assembly of newly synthesized proteins, regulating transports vesicles to the cilia and ciliogenesis</td></tr><tr><td>2D-DIGE</td><td>TPM2</td><td>Tropomyosin 2</td><td>Actin filaments, cytosol</td><td>Actin-binding protein involved in stabilizing cytoskeleton actin filaments and receptor internalization</td></tr><tr><td>2D-DIGE<br>(2 spots)</td><td>TAGLN<br>(a, b)</td><td>Transgelin</td><td>Microtubules, mitochondria, cytosol</td><td>Actin-binding protein involved in cytoskeletal organization and cell cycle arrest</td></tr><tr><td>2D-DIGE</td><td>TPM1</td><td>Tropomyosin 1</td><td>Actin filaments, cytosol</td><td>Actin-binding protein involved in stabilizing cytoskeleton actin filaments and receptor internalization</td></tr><tr><td>2D-DIGE</td><td>CDH1</td><td>Cadherin 1</td><td>Golgi apparatus, plasma membrane, cell junctions</td><td>Calcium-dependent cell adhesion protein</td></tr><tr><td>2D-DIGE</td><td>APOA4</td><td>Apolipoprotein A4</td><td>Vesicles</td><td>Actin-binding protein involved in lipoproteins secretion and metabolism</td></tr><tr><td>LC-MS/MS</td><td>KRT14</td><td>Keratin 14</td><td>Intermediate filaments</td><td>Intermediate filaments form the cytoskeleton of epithelial cells</td></tr><tr><td colspan="5"><strong>Proteins with a metabolic role</strong></td></tr><tr><td>2D-DIGE</td><td>MDH1</td><td>Malate dehydrogenase 1</td><td>Centrosome, Cytosol</td><td>Plays essential roles in the malate-aspartate shuttle and the tricarboxylic acid cycle, and an important role in mitochondrial NADH supply for oxidative phosphorylation</td></tr><tr><td>2D-DIGE</td><td>ANPEP</td><td>Aminopeptidase N</td><td>Plasma membrane</td><td>Plays a role in the final digestion of peptides generated through hydrolysis of proteins by gastric and pancreatic proteases; located in the microvillar membrane of small intestinal cells</td></tr><tr><td>2D-DIGE</td><td>ENO1</td><td>Enolase 1</td><td>Plasma membrane, cytosol</td><td>Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate</td></tr><tr><td>2D-DIGE</td><td>GALM</td><td>Galactose mutarotase</td><td>Nucleoplasm</td><td>Enzyme that catalyzes the epimerization of hexose sugars such as glucose and galactose</td></tr><tr><td>2D-DIGE</td><td>ATP5F1B</td><td>ATP Synthase F1 subunit beta</td><td>Mitochondria</td><td>Mitochondrial membrane ATP synthase from Complex V</td></tr><tr><td colspan="5"><strong>Other functions</strong></td></tr><tr><td>2D-DIGE</td><td>SERPINA3</td><td>Serpin family A member 3</td><td>Vesicles, extracellular</td><td>Serine protease inhibitor often involved in immune responses</td></tr><tr><td>2D-DIGE</td><td>HSPA5</td><td>Heat shock protein family A (Hsp70) member 5</td><td>Cytosol</td><td>Typical HSP70 chaperone involved in the folding and assembly of proteins in the endoplasmic reticulum and is a master regulator of its homeostasis</td></tr><tr><td>2D-DIGE</td><td>GSTM2</td><td>Glutathione S-transferase Mu 2</td><td>Vesicles, cytosol</td><td>Detoxification of electrophilic compounds</td></tr><tr><td>LC-MS/MS</td><td>MMP1</td><td>Matrix metallopeptidase 1</td><td>Vesicles, extracellular</td><td>Secreted protease involved in the degradation of interstitial collagens</td></tr><tr><td>LC-MS/MS</td><td>FABP4</td><td>Fatty acid-binding protein, adipocyte</td><td>Vesicles, cytosol</td><td>Lipid binding protein involved in lipid transport protein within the adipocyte</td></tr></tbody></table>

The table lists the proteomic methods used for protein detection, the official gene symbol, name, subcellular location, and function (according to Gene Ontology).

<figure><img src="image_8.png" /></figure>
<table><caption>**Table 2** Functional analysis of the differentially abundant proteins (listed in Tables 1 and 5, depending on the toxin)</caption><thead><tr><th rowspan="2">Gene ontology term category</th><th colspan="2">DON</th><th colspan="2">NX</th></tr><tr><th>Term</th><th>Benjamini</th><th>Term</th><th>Benjamini</th></tr></thead><tbody><tr><td rowspan="4">Cellular compartment</td><td>Extracellular exosome</td><td>6.4E-5</td><td>Mitochondrial nucleoid</td><td>1.1E-2</td></tr><tr><td>Cytosol</td><td>1.4E-2</td><td>Myelin sheath</td><td>7.1E-2</td></tr><tr><td>Cell-cell adherens junction</td><td>5.3E-2</td><td>Mitochondrial inner membrane</td><td>7.1E-2</td></tr><tr><td>Muscle thin filament tropomyosin</td><td>6.1E-2</td><td>Mitochondrial outer membrane</td><td>2.9E-1</td></tr><tr><td rowspan="4">Molecular function</td><td>Cadherin binding involved in cell-cell adhesion</td><td>1.3E-1</td><td>Antioxidant activity</td><td>2.7E-1</td></tr><tr><td>Actin binding</td><td>8.1E-1</td><td>Lipid binding</td><td>7.4E-1</td></tr><tr><td>Structural constituent of muscle</td><td>8.1E-1</td><td>Poly(A) RNA binding</td><td>7.4E-1</td></tr><tr><td>Glycoprotein binding</td><td>9.3E-1</td><td>Transporter activity</td><td>7.4E-1</td></tr><tr><td rowspan="4">Biological process</td><td>Cell-cell adhesion</td><td>1.0E0</td><td>Hydrogen peroxide catabolic process</td><td>5.1E-1</td></tr><tr><td>Toxin transport</td><td>1.0E0</td><td>Response to oxygen-containing compound</td><td>9.3E-1</td></tr><tr><td>Muscle filament sliding</td><td>1.0E0</td><td>Response to reactive oxygen species</td><td>9.3E-1</td></tr><tr><td>Gluconeogenesis</td><td>1.0E0</td><td>Macromolecular complex assembly</td><td>9.6E-1</td></tr></tbody></table>

Enrichment of Gene Ontology terms as a function of the cellular compartment, molecular function, and biological processes according to the DAVID bioinformatics database v6.8

<table><caption>**Table 3** Top canonical pathways enriched in differentially abundant proteins for each toxin according to Ingenuity Pathway Analysis (based on the protein lists in Tables 1 and 5)</caption><thead><tr><th>Toxin</th><th>Name</th><th>P value</th><th>Overlap</th></tr></thead><tbody><tr><td rowspan="3">DON</td><td>Gluconeogenesis I</td><td>6.39E-09</td><td>3.5% (6/171)</td></tr><tr><td>Glutathione-mediated detoxification</td><td>2.39E-04</td><td>6.2% (2/32)</td></tr><tr><td>Galactose degradation I (Leloir pathway)</td><td>3.60E-03</td><td>20.0% (1/5)</td></tr><tr><td rowspan="3">NX</td><td>Mitochondrial dysfunction</td><td>6.39E-09</td><td>3.5% (6/171)</td></tr><tr><td>Sirtuin signaling pathway</td><td>1.54E-07</td><td>2.1% (6/292)</td></tr><tr><td>Oxidative phosphorylation</td><td>2.56E-06</td><td>3.6% (4/11)</td></tr></tbody></table>

The overlap details the relative percentage (number) of differentially regulated proteins for each pathway, depending on the toxin

The secretomes of intestinal explants exposed to NX were highly enriched in DAPs belonging to the mitochondria (14

DAPs). The list of DAPs was completed with structural proteins (4 DAPs) and proteins with other functions (6 DAPs; Table 5).

Based on the functional analysis, most of the DAPs were contained in mitochondria (Table 2) and enriched pathways were linked with mitochondrial functions (Table 5). Cellular and molecular functions connected with NX-related DAPs indicated responses to oxidative stress as well as binding of lipids and small molecules such as RNAs (Tables 2 and 3). In the present study, we observed that the changes in the secretomes of jejunal explants exposed to NX reflected alteration in cell shape and adhesion, as well as alteration in the regulation of inflammatory response. This is in accordance with previous results, showing that NX regulates genes involved in cell proliferation, differentiation, apoptosis, and growth, and particularly in immune and pro-inflammatory responses (Pierron et al. 2022). In contrast to DON, most DAPs in NX-treated samples were mitochondrial proteins. The enrichment in mitochondrial proteins of the jejunal secretomes in response to NX is likely associated with

<table><caption>**Table 4** Molecular and cellular functions enriched in differentially abundant proteins for each toxin according to Ingenuity Pathway Analysis (based on the protein lists in Tables 1 and 5)</caption><thead><tr><th>Toxin</th><th>Name</th><th>P value range</th><th># Molecules</th></tr></thead><tbody><tr><td rowspan="3">DON</td><td>Cellular assembly and organization</td><td>1.36E-02 to 1.46E-06</td><td>8</td></tr><tr><td>Cellular function and maintenance</td><td>1.32E-02 to 1.46E-06</td><td>13</td></tr><tr><td>Cell death and survival</td><td>1.38E-02 to 5.78E-06</td><td>12</td></tr><tr><td rowspan="3">NX</td><td>Energy production</td><td>1.76E-02 to 5.74E-09</td><td>14</td></tr><tr><td>Nucleic acid metabolism</td><td>1.67E-02 to 5.74E-09</td><td>12</td></tr><tr><td>Small molecule biochemistry</td><td>2.28E-02 to 5.74E-09</td><td>18</td></tr></tbody></table>

# Molecules gives the number of differentially regulated proteins with the respective functions, depending on the toxin
<figure><img src="image_9.png" /><figcaption>**Table 5** Proteins in the secretomes of intestinal explants (n = 5 for 2D-DIGE; n = 3 for label-free LC-MS/MS analysis) which were differentially regulated due to exposure to NX</figcaption></figure>

<table><thead><tr><th>Technique</th><th>Official gene symbol</th><th>Protein name</th><th>Subcellular location</th><th>Function</th></tr></thead><tbody><tr><td colspan="5"><strong>Mitochondrial proteins</strong></td></tr><tr><td>2D-DIGE</td><td><strong>ATP5F1B</strong></td><td><strong>ATP synthase subunit beta</strong></td><td>Mitochondria</td><td>Mitochondrial membrane ATP synthase from complex V</td></tr><tr><td>LC-MS/MS</td><td>HADHB</td><td>Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta</td><td>Mitochondria</td><td>Mitochondrial enzyme</td></tr><tr><td>LC-MS/MS</td><td>MAOA</td><td>Monoamine oxidase A</td><td>Mitochondria, Cytosol</td><td>Mitochondrial enzyme</td></tr><tr><td>LC-MS/MS</td><td>PHB</td><td>Prohibitin</td><td>Mitochondria</td><td>Mitochondrial protein that stabilizes mitochondrial respiratory enzymes and maintains mitochondrial integrity; plays a role in mitophagy</td></tr><tr><td>LC-MS/MS</td><td><strong>ATP5F1B</strong></td><td><strong>ATP synthase F1 subunit beta</strong></td><td>Mitochondria</td><td>Mitochondrial membrane ATP synthase from complex V</td></tr><tr><td>LC-MS/MS</td><td>VDAC1</td><td>Voltage-dependent anion-selective channel protein 1</td><td>Vesicles</td><td>Major component of the outer mitochondrial membrane and involved in apoptosis</td></tr><tr><td>LC-MS/MS</td><td>ATP5PD</td><td>ATP synthase subunit d, mitochondrial</td><td>Mitochondria</td><td>Mitochondrial membrane ATP synthase from complex V</td></tr><tr><td>LC-MS/MS</td><td>ALDH18A1</td><td>Delta-1-pyrroline-5-carboxylate synthase</td><td>Mitochondria</td><td>Mitochondrial enzyme</td></tr><tr><td>LC-MS/MS</td><td>ATP5F1A</td><td>ATP synthase F1 subunit alpha</td><td>Mitochondria</td><td>Mitochondrial membrane ATP synthase from complex V</td></tr><tr><td>LC-MS/MS</td><td>ATP5F1C</td><td>ATP synthase F1 subunit gamma</td><td>Mitochondria</td><td>Mitochondrial membrane ATP synthase from complex V</td></tr><tr><td>LC-MS/MS</td><td>SLC25A5</td><td>ADP/ATP translocase 2</td><td>Mitochondria</td><td>Mitochondrial carrier subfamily of solute carrier protein genes</td></tr><tr><td>LC-MS/MS</td><td>LOC100156879</td><td>Ubiquinol-cytochrome c reductase core protein 1 (90 identity)</td><td>Mitochondria</td><td>Component of the mitochondrial electron transport chain that drives oxidative phosphorylation</td></tr><tr><td>LC-MS/MS</td><td>PCK1</td><td>Phosphoenolpyruvate carboxykinase</td><td>Mitochondria, cytosol, endoplasmic reticulum</td><td>Cytosolic or mitochondrial enzyme involved in the regulation of gluconeogenesis</td></tr><tr><td>LC-MS/MS</td><td>STIP1</td><td>Stress induced phosphoprotein 1</td><td>Nucleoplasm, plasma membrane, cytosol</td><td>Regulates both the conformations and ATPase cycles of HSP70 and HSP90</td></tr><tr><td colspan="5"><strong>Structural proteins</strong></td></tr><tr><td>2D-DIGE</td><td><strong>CCT8</strong></td><td><strong>Chaperonin containing TCP1 subunit 8</strong></td><td>Nucleoplasm, intermediate filaments, cytosol</td><td>Involved in the transport and assembly of newly synthesized proteins that regulate the transport of vesicles to the cilia and ciliogenesis</td></tr><tr><td>2D-DIGE</td><td><strong>APOA4</strong></td><td><strong>Apolipoprotein A4</strong></td><td>Vesicles</td><td>Actin-binding protein involved in lipoproteins secretion and metabolism</td></tr><tr><td>LC-MS/MS</td><td>ACTN2</td><td>Alpha-actinin-2 isoform</td><td>Actin filaments</td><td>Cytoskeletal protein found in microfilament bundles and adherens-type junctions</td></tr><tr><td>LC-MS/MS</td><td>DES</td><td>Desmin</td><td>Intermediate filaments</td><td>Intermediate filament connecting myofibrils to each other and to the plasma membrane</td></tr><tr><td colspan="5"><strong>Other functions</strong></td></tr><tr><td>2D-DIGE</td><td>HBB</td><td>Hemoglobin subunit beta</td><td>Cytosol, vesicles</td><td>Oxygen transport protein also involved in the regulation of inflammation</td></tr></tbody></table>
<table><caption>**Table 5** (continued)</caption><thead><tr><th>Technique</th><th>Official gene symbol</th><th>Protein name</th><th>Subcellular location</th><th>Function</th></tr></thead><tbody><tr><td>2D-DIGE</td><td>PEBP1</td><td>Phosphatidylethanolamine binding protein 1</td><td>Plasma membrane, cytosol</td><td>Modulator of the MAP kinase, NF-kappa B, and glycogen synthase kinase-3 signaling pathways</td></tr><tr><td>2D-DIGE</td><td>GSTM</td><td>Glutathione S-transferase mu</td><td>Vesicles, cytosol</td><td>Detoxification of electrophilic compounds</td></tr><tr><td>2D-DIGE</td><td>FABP1</td><td>Fatty Acid binding protein 1</td><td>Nucleoplasm, cytosol</td><td>Lipid binding protein involved in lipid uptake and transport within the hepatocyte</td></tr><tr><td>2D-DIGE</td><td>HSPA5</td><td><strong>Heat shock protein family A (Hsp70) member 5</strong></td><td>Cytosol</td><td>Typical HSP70 chaperone involved in the folding and assembly of proteins in the endoplasmic reticulum; master regulator of its homeostasis</td></tr><tr><td>LC-MS/MS</td><td>MMPI</td><td><strong>Matrix metallopeptidase 1</strong></td><td>Vesicles, extracellular</td><td>Secreted protease involved in the degradation of interstitial collagens</td></tr></tbody></table>

The table lists the proteomic methods used for protein detection, the official gene symbol, name, subcellular location, and function (according to Gene ontology). Proteins found regulated also in DON exposure are in bold

the increased inflammation caused by this toxin compared to DON. Indeed, inflammation promotes the secretion of mitochondrial content (Todkar et al. 2021). The presence of mitochondrial content in the extracellular space can mediate cell-to-cell communication and repair and function as an activator of the immune response (Miliotis et al. 2019). When contained in mitochondrial-derived vesicles, extracellular mitochondrial proteins reflect an enhanced oxidative stress and mitochondrial toxicity (Vasam et al. 2021). In our conditions, it was not possible to distinguish if the identified DAPs are free in the surrounding medium or contained in vesicles or whole mitochondria. Further analyses are needed to investigate if NX is especially toxic to cell mitochondria, and if the secretion of mitochondrial-derived vesicles is important for the increased inflammation induced by NX compared to DON.

In terms of risk analysis, the present results contribute with new information concerning the difference between DON and NX toxicity. Indeed, NX toxicity is associated with the release of extracellular mitochondrial proteins in exposed cells. Quantification of this phenomenon, in comparison with common effects such as inflammation, would be useful to characterize the combined toxicity of DON and NX and their possible interactions.

## Conclusion

Our results show that the secretomes of jejunal explants exposed to DON and NX reflect the known histological lesions as well as the metabolic changes associated with cellular stress induced by the inflammation promoted by both mycotoxins. Our results also show that NX but not DON toxicity promotes the release of mitochondrial proteins, a phenomenon possibly linked with the pro-inflammatory effects of NX. Our results further suggest that NX may be toxic to mitochondria, and call for further research on the role of mitochondria and the production of mitochondrial-derived vesicles in NX toxicity. The present results provide new evidence that DON and NX toxicity may not simply be a matter of different potencies of the same effects, contrary to what was previously thought. The comparative assessment of mitochondrial toxicity could be useful to investigate the differential toxicity of DON and NX as well as their combined effects.

**Supplementary Information** The online version contains supplementary material available at https://doi.org/10.1007/s00204-022-03318-x.

**Acknowledgements** The authors would like to thank Prof J David Miller for the generous gift of NX mycotoxin and helpful comments on the manuscript. We acknowledge the technical help of colleagues at Toxalim, especially Philippe Pinton, Anne Marie Cossalter, Mickael Albin, Joëlle Lafitte, and Alix Pierron.
**Funding** Open access funding provided by University of Veterinary Medicine Vienna. This project received funding from the Agence Nationale de la Recherche (ANR) grant EmergingMyco (ANR-18-CE34-0014). Scientist mobility and partial support for material costs were provided by an Integrated Action between the Toxalim (Research center in food toxicology) at the INRAE Occitanie-Toulouse Centre, Toulouse, France and the Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria (PHC Amadeus France No. 42210TC; Bundesministerium für Wissenschaft und Forschung, Austria, FR 08/2019).

## Declarations

**Conflict of interest** The authors declare no conflict of interest.

**Open Access** This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

## References

Aitken A, Miller JD, McMullin DR (2019) Isolation, chemical characterization and hydrolysis of the trichothecene 7a-hydroxy, 15-deacetylcalonectrin (3ANX) from *Fusarium graminearum* DAOMC 242077. *Tetrahedron Lett* 60:852-856. https://doi.org/10.1016/j.tetlet.2019.02.025

Alassane-Kpembi I, Puel O, Pinton P, Cossalter AM, Chou TC, Oswald IP (2017b) Co-exposure to low doses of food contaminants deoxynivalenol and nivalenol has a synergistic inflammatory effect on intestinal explants. Arch Toxicol 91:2677-2687. https://doi.org/10.1007/s00204-016-1902-9

Alassane-Kpembi I, Gerez JR, Cossalter AM, Neves M, Laffitte J, Naylies C, Lippi Y, Kolf-Clauw M, Bracarense APL, Pinton P, Oswald IP (2017a) Intestinal toxicity of the type B trichothecene mycotoxin fusarenon-X: whole transcriptome profiling reveals new signaling pathways. Sci Rep 7:7530. https://doi.org/10.1038/s41598-017-07155-2

Alassane-Kpembi I, Pinton P, Hupé JF, Neves M, Lippi Y, Combes S, Castex M, Oswald IP (2018) *Saccharomyces cerevisiae* boulardii reduces the deoxynivalenol-induced alteration of the intestinal transcriptome. Toxins 10:199. https://doi.org/10.3390/toxins10050199

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254. https://doi.org/10.1006/abio.1976.9999

Chen L, Yang J, Wang H, Yang X, Zang C, Zhao Z, Wang J (2022) NX toxins: new threat posed by *Fusarium graminearum* species complex. Trends Food Sci Technol 119:179-191. https://doi.org/10.1016/j.tifs.2021.11.027

Crippin T, Renaud JB, Sumarah MW, Miller JD (2019) Comparing genotype and chemotype of *Fusarium graminearum* from cereals

in Ontario. Canada Plos One 14:e0216735. https://doi.org/10.1371/journal.pone.0216735

Crippin T, Limay-Rios V, Renaud J, Schaafsma A, Sumarah M, Miller JD (2020) *Fusarium graminearum* populations from corn and wheat in Ontario. Canada World Mycotoxin J 13:355-366. https://doi.org/10.3920/WMJ2019.2532

Gale LR, Ward TJ, Kistler HC (2010) A subset of the newly discovered Northland population of *Fusarium graminearum* from the US does not produce the B-type trichothecenes DON, 15ADON, 3ADON or NIV. In: Proceedings of the National *Fusarium* Head Blight Forum, pp 48-49

García GR, Payros D, Pinton P, Dogi CA, Laffitte J, Neves M, González Pereyra ML, Cavaglieri LR, Oswald IP (2018) Intestinal toxicity of deoxynivalenol is limited by *Lactobacillus rhamnosus* RC007 in pig jejunum explants. Arch Toxicol 92:983-993. https://doi.org/10.1007/s00204-017-2083-x

Garreau de Loubresse N, Prokhorova I, Holtkamp W, Rodnina MV, Yusupova G, Yusupov M (2014) Structural basis for the inhibition of the eukaryotic ribosome. Nature 513:517-522. https://doi.org/10.1038/nature13737

Gebhard C, Miller I, Hummel K, Neschi M, Schlosser S, Walter I (2018) Comparative proteome analysis of monolayer and spheroid culture of canine osteosarcoma cells. J Proteom 177:124-136. https://doi.org/10.1016/j.jprot.2018.01.006

Graziani F, Pinton P, Olleik H, Pujol A, Nicoletti C, Sicre M, Quinson N, Ajandouz EH, Perrier J, Pasquale ED, Oswald IP, Maresca M (2019) Deoxynivalenol inhibits the expression of trefoil factors (TFF) by intestinal human and porcine goblet cells. Arch Toxicol 93:1039-1049. https://doi.org/10.1007/s00204-019-02425-6

Gutiérrez AM, Sotillo J, Schlosser S, Hummel K, Miller I (2019) Towards understanding non-infectious growth-rate retardation in growing pigs. Proteomes 7:31. https://doi.org/10.3390/proteomes7030031

Hathout Y (2007) Approaches to the study of the cell secretome. Expert Rev Proteom 4:239-248. https://doi.org/10.1586/14789450.4.2.239

Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57. https://doi.org/10.1038/nprot.2008.211

JEFCA (2011) 'Deoxynivalenol'. 72nd Joint FAO/WHO expert committee on food additives and contaminants. World Health Organisation, Geneva, p 791

Knutsen HK, Alexander J, Barregard L, Bignami M, Brüschweiler B, Ceccatelli S, Cottrill B, Dinovi M, Grasl-Kraupp B, Hogstrand C, Hoogenboom LR, Nebbia CS, Oswald IP, Petersen A, Rose M, Roudot AC, Schwerdtle T, Vleminckx C, Vollmer G, Wallace H. De Saeger S, Eriksen GS, Farmer P, Fremy JM, Gong YY, Meyer K, Naegeli H, Parent-Massin D, Rietjens I, van Egmond H, Altieri A, Eskola M, Gergelova P, Ramos Bordajandi L, Benkova B, Dorr B, Gkrillas A, Gustavsson N, van Manen M, Edler L (2017) Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed. EFSA J 15:e04718. https://doi.org/10.2903/j.efsa.2017.4718

Kolf-Clauw M, Sassahara M, Lucioli J, Rubira-Gerez J, Alassane-Kpembi I, Lyazhri F, Borin C, Oswald IP (2013) The emerging mycotoxin, enniatin B1, down-modulates the gastrointestinal toxicity of T-2 toxin in vitro on intestinal epithelial cells and ex vivo on intestinal explants. Arch Toxicol 87:2233-2241. https://doi.org/10.1007/s00204-013-1067-8

Lahjouji T, Bertaccini A, Neves M, Puel S, Oswald IP, Soler L (2020) Acute exposure to zearalenone disturbs intestinal homeostasis by modulating the wnt/β-catenin signaling pathway. Toxins 12:113. https://doi.org/10.3390/toxins12020113 (PMID: 32053894)

Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS et al (2010) Exosome secreted by MSC reduces myocardial ischemia/
reperfusion injury. Stem Cell Res 4:214-222. https://doi.org/10.1016/j.scr.2009.12.003

Lucioli J, Pinton P, Callu P, Laffitte J, Grosjean F, Kolf-Clauw M, Oswald IP, Bracarense APFRL (2013) The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestine: interest of ex vivo models as an alternative to in vivo experiments. Toxicon 66:31-36. https://doi.org/10.1016/j.toxicon.2013.01.024

Miliotis S, Nicolalde B, Ortega M, Yepez J, Caicedo A (2019) Forms of extracellular mitochondria and their impact in health. Mitochondrion 48:16-30. https://doi.org/10.1016/j.mito.2019.02.002

Miller I, Radwan M, Strobl B, Müller M, Gemeiner M (2006) Contribution of cell culture additives to the two-dimensional protein patterns of mouse macrophages. Electrophoresis 27:1626-1629. https://doi.org/10.1002/elpS.200500744

Miller I (2012) Application of 2D DIGE in animal proteomics. Methods Mol Biol 854:373-396. https://doi.org/10.1007/978-1-61779-573-2_26

Miller JD (2016) Mycotoxins in food and feed: a challenge for the 21st century Li D-W Biol microfungi. Springer, Switz, pp 469-493

Payros D, Alassane-Kpembi I, Pierron A, Loiseau N, Pinton P, Oswald IP (2016) Toxicology of deoxynivalenol and its acetylated and modified forms. Arch Toxicol 90:2931-2957. https://doi.org/10.1007/s00204-016-1826-4

Payros D, Menard S, Laffitte J, Neves M, Tremblay-Franco M, Luo S, Fouche E, Snini SP, Theodorou V, Pinton P, Oswald IP (2020) The food contaminant, deoxynivalenol, modulates the Thelper/Treg balance and increases inflammatory bowel diseases. Arch Toxicol 94:3173-3184. https://doi.org/10.1007/s00204-020-02817-z

Payros D, Garofalo M, Pierron A, Soler-Vasco L, Al-Ayoubi C, Maruo VM, Alassane-Kpembi I, Pinton P, Oswald IP (2021a) 'Mycotoxins in human food: a challenge for research. Cah Nutr Diet 56:170-183. https://doi.org/10.1016/j.cnd.2021a.02.001

Payros D, Alassane-Kpembi I, Laffitte J, Lencina C, Neves M, Bracarense AP, Pinton P, Ménard S, Oswald IP (2021b) Dietary exposure to the food contaminant deoxynivalenol triggers colonic breakdown by activating the mitochondrial and the death receptor pathways. Mol Nutr Food Res 65:e2100191. https://doi.org/10.1002/mnfr.2021b00191

Pestka JJ (2010) Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Arch Toxicol 84:663-679. https://doi.org/10.1007/s00204-010-0579-8

Pierron A, Neves M, Puel S, Lippi Y, Soler L, Miller JD, Oswald IP (2022) Intestinal toxicity of the new type A trichothecenes, NX and 3ANX. Chemosphere 288:132415. https://doi.org/10.1016/j.chemosphere.2021.132415

Pinton P, Nougayrède JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, Bracarense AP, Kolf-Clauw M, Oswald IP (2009) The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol 237:41-48. https://doi.org/10.1016/j.taap.2009.03.003

Pinton P, Tsybulskyy D, Lucioli J, Laffitte J, Callu P, Lyazhri F, Grosjean F, Bracarense AP, Kolf-Clauw M, Oswald IP (2012) Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. Toxicol Sci 130:180-190. https://doi.org/10.1093/toxsci/kfs239

Pinton P, Oswald IP (2014) Trichothecenes on the intestine: a review. Toxins 6:1615-1643. https://doi.org/10.3390/toxins

Rabilloud T, Lescuyer P (2015) Proteomics in mechanistic toxicology: history, concepts, achievements, caveats, and potential. Proteomics 15:1051-1074. https://doi.org/10.1002/pmic.201400288

Swindle MM (2012) The development of swine models in drug discovery and development. Future Med Chem 4:1771-1772. https://doi.org/10.4155/fmc.12.113

Terciolo C, Maresca M, Pinton P, Oswald IP (2018) Review article: role of satiety hormones in anorexia induction by trichothecene mycotoxins. Food Chem Toxicol 121:701-714. https://doi.org/10.1016/j.fct.2018.09.034

Todkar K, Chikhi L, Desjardins V, El-Mortada F, Pépin G, Germain M (2021) Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. Nat Commun 12:1971. https://doi.org/10.1038/s41467-021-21984-w

Varga E, Wiesenberger G, Hametner C, Ward TJ, Dong Y, Schofbeck D, McCormick S, Broz K, Stuckler R, Schuhmacher R, Kriska R, Kistler HC, Berthiller F, Adam G (2015) New tricks of an old enemy: isolates of *Fusarium graminearum* produce a type A trichothecene mycotoxin. Environ Microbiol 17:2588-2600. https://doi.org/10.1111/1462-2920.12718

Varga E, Wiesenberger G, Woelflingseder L, Twaruschek K, Hametner C, Vaclavikova M, Malachova A, Marko D, Berthiller F, Adam G (2018) Less-toxic rearrangement products of NX-toxins are formed during storage and food processing. Toxicol Lett 284:205-212. https://doi.org/10.1016/j.toxlet.2017.12.016

Vasam G, Nadeau R, Cadete VJJ, Lavallée-Adam M, Menzies KJ, Burelle Y (2021) Proteomics characterization of mitochondrial-derived vesicles under oxidative stress. FASEB J 35:e21278. https://doi.org/10.1096/fj.202002151R

Vin K, Riviere G, Leconte S, Cravedi JP, Fremy JM, Oswald IP, Roudot AC, Vasseur P, Jean J, Hulin M, Sirot V (2020) Dietary exposure to mycotoxins in the French infant total diet study. Food Chem Toxicol 140:111301. https://doi.org/10.1016/j.fct.2020.111301

Woelflingseder L, Del Favero G, Blazevic T, Heiss EH, Haider M, Warth B, Adam G, Marko D (2018) Impact of glutathione modulation on the toxicity of the *Fusarium* mycotoxins deoxynivalenol (DON), NX-3 and butenolide in human liver cells. Toxicol Lett 299:104-117. https://doi.org/10.1016/j.toxlet.2018.09.007

Woelflingseder L, Gruber N, Adam G, Marko D (2020) Pro-inflammatory effects of NX-3 toxin are comparable to deoxynivalenol and not modulated by the Co- occurring pro-oxidant aurofusarin. Microorganisms 8:603. https://doi.org/10.3390/microorganisms8040603

**Publisher's Note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.